Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic
Bharat Biotech Intl to conduct phase 2 trials for TB vaccine
Govt expert panel recommends vaccine for pneumococcal infections
DCGI's SEC to hold discussion on "five arms" booster dose
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in...
Biological E announces CDSCO's approval of its PCV14 vaccine
India's first mRNA COVID-19 vaccine to get EUA soon
SEC recommends India's first indigenously developed vaccine
SEC to discuss India's first indigenously developed vaccine again
New Delhi [India] June 15 (ANI): The first indigenously developed quadrivalent human papillomavirus (qHPV)...
SEC seek more data from SII over Covovax for 7-12 age group
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on...
Bharat Biotech asked to give more data on COVID vaccine Covaxin
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...
SEC's recommends Corbevax COVID-19 vaccines for kids aged 5-11
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India...
DCGI to discuss to use COVID-19 vaccines for 5-12 age group
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller...
Copyright © aninews.in | All Rights Reserved.